Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Johnson & Johnson's Remicade meets key goal in pediatric ulcerative colitis study
Yahoo/AP
Mon, 05/9/11 - 06:48 pm
Tags:
JNJ, ulcerative colitis, Remicade
J&J Files New Concerta Lawsuit Against Impax Labs
Drug Discovery & Development
Mon, 05/9/11 - 11:06 am
Tags:
JNJ, Concerta, Impax
Crohn's patients respond to J&J's Stelara in study
Reuters
Mon, 05/9/11 - 09:22 am
Tags:
JNJ, Stelara, Crohn's Disease
J&J, Generics Makers to Revamp Children's Tylenol Products
Motley Fool
Fri, 05/6/11 - 08:56 am
Tags:
JNJ, generics, Tylenol, acetaminophen
Smith & Nephew not jealous over Synthes/JNJ union
Mass Device
Thu, 05/5/11 - 09:33 pm
Tags:
Smith & Nephew, Synthes, JNJ, acquisitions
Johnson & Johnson CFO: Synthes deal doesn't mean we're done
http://www.massdevice.com/news/johnson-johnson-cfo-synthes-deal-doesnt-mean-were-done
Tue, 05/3/11 - 10:54 pm
Tags:
Synthes, JNJ, acquisitions
Biotech Calendar: Key Dates for May
Seeking Alpha
Mon, 05/2/11 - 12:42 pm
Tags:
biotech, Columbia Laboratories, KV Pharmaceutical, Dendreon, Vertex Pharmaceuticals, MannKind, Alimera, Merck, NPS Pharmaceuticals, Ironwood, BioMimetic Therapeutics, Lexicon Pharmaceuticals, Avanir, Optimer, JNJ
Johnson & Johnson / Synthes: Should the Cash Have Been Used Differently?
Seeking Alpha
Mon, 05/2/11 - 09:11 am
Tags:
M&A, JNJ, Synthes
Zeltia to Miss $10 Million Yondelis Payment After U.S. Setback
Bloomberg
Sun, 05/1/11 - 04:23 pm
Tags:
Zeltia, Yondelis, ovarian cancer, JNJ
Drug Companies Stocks Underperfoming: JNJ, NVS, PFE
Trader's Huddle
Sat, 04/30/11 - 11:27 am
Tags:
JNJ, Novartis, Pfizer
Johnson & Johnson’s Centocor Withdraws Trabectedin Application
Bloomberg
Sat, 04/30/11 - 10:04 am
Tags:
JNJ, Janssen Biotech, Trabectedin, ovarian cancer
Fitch considers J&J downgrade on buyout
Yahoo/AP
Sat, 04/30/11 - 10:03 am
Tags:
JNJ
Are Top-Earning Pharma CEOs (We Mean You, William Weldon) Worth the $$$?
WSJ Online
Fri, 04/29/11 - 10:17 am
Tags:
Pharma CEOs, executive pay, William Weldon, JNJ
CEO: J&J learned recall lessons, will bounce back
Google/Associated Press
Fri, 04/29/11 - 04:37 am
Tags:
CEO, JNJ, recalls
Johnson & Johnson Prostate Cancer Drug Approved by U.S. FDA
Bloomberg
Thu, 04/28/11 - 10:00 pm
Tags:
prostate cancer, JNJ, FDA, abiraterone
Zimmer, Stryker May Seek to Buy to Keep Pace With J&J Deal
Bloomberg
Thu, 04/28/11 - 09:23 am
Tags:
Zimmer, Stryker, JNJ, acquisitions
J&J Agrees to Buy Synthes for $21.3 Billion to Gain Devices
Bloomberg Businessweek
Thu, 04/28/11 - 08:44 am
Tags:
JNJ, Synthes, acquisitions
J.&J. May Have More Acquisitions in Mind
NY Times, NY
Thu, 04/28/11 - 07:14 am
Tags:
JNJ, M&A
J&J CEO: Most product recalls are behind us; with changes, we'll win back public trust, sales
Yahoo/AP
Wed, 04/27/11 - 12:16 pm
Tags:
William Weldon, Pharma CEOs, JNJ, recalls
Digesting Synthes May Not Be Easy for Johnson & Johnson
WSJ Online
Wed, 04/27/11 - 12:06 pm
Tags:
M&A, JNJ, Synthes, Device

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.